---
title: "Indications, advantage, and follow-up of RFA for lung tumors"
---
RFA: can be performed on lesions between 1.5 and 5.2 cm
Most common complication is PTX
Effectiveness of RFA is similar to external beam XRT
Advantage: limited effect on pulmonary function, and can be performed without concern to prior therapy.

Follow-up:
Findings suggestive of residual/recurrent disease- nodular peripheral enhancement &gt; 10 mm, central enhancement, growth of RFA zone after 3 months (after 6 months considered definite), increased metabolic activity after 2 months, residual activity centrally.

